MedAvante, Inc. provides signal detection solutions in clinical trials of treatments for central nervous system disorders. It offers Virgil investigative study platform for site-based assessments; and MedAvante central ratings for live assessments. The firm also offers scientific risk reduction services. The company was founded by Paul M. Gilbert, Amy Ellis, Peter B. Tilles, Livingston Johnson and Avik Roy in 2002 and is headquartered in Hamilton, NJ.

Xiangyu Pharmaceutical Co., Ltd. engages in manufacturing, research and development and sales of Chinese and western medicines. It offers red blood enriching oral liquid and ibuprofen suspension. The company was founded on October 23, 2000 and is headquartered in Linyi, China.

Medidata is an unified life science platform. They help generate the evidence and insights to help pharmaceutical, biotech, medical device and diagnostics companies, and academic researchers accelerate value, minimize risk, and optimize outcomes. Their products and solutions include clinical cloud, patient cloud, decenteralized clinical trials, and more.

IMS Health is an American company that provides information, services and technology for the healthcare industry. IMS stands for Intercontinental Medical Statistics. It is the largest vendor of U.S. physician prescribing data. IMS Health was founded in 1954 by Bill Frohlich and David Dubow. In 2010, IMS Health was taken private by TPG Capital, CPP Investment Board and Leonard Green & Partners. The company went public on April 4, 2014 and began trading on the NYSE under the symbol IMS. Ari Bousbib is IMS Health’s Chairman and CEO. Bousbib, formerly a longtime senior executive at United Technologies Corporation, joined the company in September 2010. IMS Health is headquartered in Danbury, Connecticut.

Hunan Keyi Cloud Health Technology Co., Ltd., established on 2021-09-03, Business scope includes general items:Remote Health Management Services;Health Consulting Services(Does not include medical services);software development;software sales;Information system integration service;Software outsourcing service;Information system operation and maintenance services;Network and Information Security Software Development;Wholesale of computer software, hardware and auxiliary equipment;Retailing of computer software, hardware and auxiliary equipment;IC Design;integrated circuit manufacturing;IC sales;Information Technology Consulting Services;Internet equipment sales;Cloud Computing Equipment Sales;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Computer System Services;Computer and Office Equipment Repair;Industrial Engineering Design Services;Security System Monitoring Services;Office Equipment Sales;Sales of Class II Medical Devices;Sales of Class I Medical Devices;Office Supplies Sales;internet data service;Big data service;data processing services;Blockchain technology related software and services;Artificial intelligence public data platform;Data processing and storage support services;Engineering and Technology Research and Experimental Development;Digital Video Surveillance System Sales;Audio Equipment Sales(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).licensed items:Class III medical device business;Construction engineering design;Residential interior decoration;Construction Engineering Construction;Internet information service;The second type of value-added telecommunications services(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments).

Taimei Technology provides a cloud platform for clinical research collaboration. It is dedicated to propelling biopharmaceutical industry development through technology with a focus in the field of clinical research and pharmacovigilance. Taimei Technology cloud platform was designed for clinical research collaboration between sponsors, sites, CROs, patients, regulatory agencies and third-party providers. Its platform offers 6 technology-enabled solutions encompassing data management, project management, electronic regulatory submission, central medical imaging, pharmacovigilance, and drug logistics. Its clients include pharmaceutical enterprises, CRO and research institutes. The company was founded in 2013 and is headquartered in Jiaxing, Zhejiang, China.

Shanghai Taimei Nebula Digital Technology Co., Ltd., established on 2017-09-07, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;data processing services;Information system integration service;Business Management Consulting;Information Technology Consulting Services;translation service;Software outsourcing service;Data processing and storage support services;software development;Medical Research and Experimental Development;General merchandise sales;Office Supplies Sales.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Hefei Jinyue Pharmaceutical Co., Ltd., established on 2004-08-09, Business scope includes licensed projects:pharmaceutical production;Drug Wholesale;Pharmaceutical commissioned production;Cosmetic production;Health food production;Health food sales;Production of tea products;Production of hygiene products and single-use medical products;liquor business;Production of Class II Medical Devices;food production;Food Internet Sales(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)General project:Sales of Class II Medical Devices;food business(Only sell prepackaged food);Production of Class I Medical Devices;Production of protective equipment for medical personnel(Ι class medical device);Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Chinese herbal medicine planting;Chinese herbal medicine acquisition;real estate herbal medicine(Does not contain Chinese herbal medicine)buy and sell;internet sales(Except for products that require a license for sale)(Except for licensed business,Can independently operate projects that are not prohibited or restricted by laws and regulations)

R.P. Scherer Technologies LLC, a subsidiary of Catalent, Inc., is an American company that develops, manufactures and sells oral, topical, sterile and inhaled forms of drug delivery products.

Optimal Strategix Group is a technology company. They provide technology and analytic services. They develop and deliver technology-driven marketing solutions. The company develops account intelligence mobile applications, which enable field sales representatives to collect customer information for profiling, segmentation, insights, and targeted collateral presentation at the individual customer level.

Peking University First Hospital is a company headquartered in Beijing, China and ultimately controlled by the Government of China. The firm operates as a hospital.

Jiangsu Wanbang Biopharmaceuticals Co., Ltd. engages in the manufacture of biopharmaceutical products. Its products include insulin, febuxostate tablets, heparin sodium, endocrine products, cardiovascular products, biochemical products, Chinese medicine, and Chinese herbal powders. The company was founded in 1974 and is headquartered in Xuzhou, China.

Yaoyanshe is a CRO technology platform. They provide CRO services such as clinical monitoring, project management, registration affairs, biostatistics, pharmacovigilance, and medical affairs. They also provide SMO services. Yaoyanshe addresses the industry's most pressing issues and advances the objective of more effective pharmaceutical research and development.

Shanghai Nuclear Engineering Research & Design Institute is a company headquartered in Shanghai, China and ultimately controlled by the Government of China. The firm operates as a research and design institute for nuclear electric power in China.

Shanghai Fosun Pharmaceutical Group Co., Ltd. engages in the development, manufacture and sale of pharmaceutical products and medical equipment, import and export of medical equipment, healthcare services, and the provision of related and other consulting services and investment management. It operates through the following business segment: Pharmaceutical Manufacturing and R&D; Healthcare Service; Medical Devices and Medical Diagnosis; Pharmaceutical Distribution and Retail; and Other Business Operations. The Pharmaceutical Manufacturing and R&D segment involves in the production, sale, and research of medicine. The Healthcare Service segment provides healthcare service and hospital management. The Medical Devices and Medical Diagnosis segment focuses on the production and sale of medical equipment and diagnostic products. The Pharmaceutical Distribution and Retail segment issue retail and wholesale of medicine. The Other Business Operations segment comprises business that is different from the role of other segments. The company was founded on January 14, 1994 and is headquartered in Shanghai, China.

Clinical Supplies Management, Inc. engages in the provision of clinical trial supply solutions for pharmaceutical and biotechnology companies. Its clinical services include packaging and labeling; storage and global distribution; chain management consulting; and returns, reconciliation, and destruction. The company was founded by Gerald E. Finken in 1997 and is headquartered in Fargo, ND.

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products, including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.